Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | F2R | P25116 | 1/20 | 0.33 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.33 |
| ▸ | TACR1 | P25103 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | DRD5 | P21918 | 1/20 | 0.32 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.32 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3964413 | 0.91 | HTT (0.36) | LMNAGAAHTTSMN1; SMN2CHRM2 | |
| SCHEMBL3964433 | 0.90 | LMNA (0.40) | LMNAGAAHTTSMN1; SMN2CHRM2 | |
| SCHEMBL15261923 | 0.89 | F2R (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL3969107 | 0.88 | TACR1 (0.35) | LMNAGAAHTTSMN1; SMN2CNR1 | |
| SCHEMBL2929652 | 0.88 | LMNA (0.41) | LMNAGAAHTTSMN1; SMN2CNR1 | |
| SCHEMBL1581294 | 0.84 | F2R (0.43) | LMNAGAAHTTSMN1; SMN2CHRM2 | |
| SCHEMBL3804873 | 0.84 | SMN1; SMN2 (0.40) | LMNAGAAHTTSMN1; SMN2CNR1 | |
| SCHEMBL3974787 | 0.82 | LMNA (0.41) | LMNAGAAHTTSMN1; SMN2CNR1 | |
| SCHEMBL3760972 | 0.81 | F2R (0.44) | LMNAGAAHTTSMN1; SMN2CHRM2 | |
| SCHEMBL3798403 | 0.81 | F2R (0.49) | LMNAGAAHTTSMN1; SMN2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130252948-A1 | Substituted piperidines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20090306139-A1 | HETEROARYL-SUBSTITUTED PIPERIDINES | BAYER HEALTHCARE AG (DE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306139-A1 | HETEROARYL-SUBSTITUTED PIPERIDINES | VHL, PIGO, PLIN3 | LMNA 217/4885GAA 634/4885HTT 878/4885 |
| US-20130252948-A1 | Substituted piperidines | VHL, PIR, PTGIS | LMNA 396/4885GAA 964/4885HTT 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.